trending Market Intelligence /marketintelligence/en/news-insights/trending/h0EIHYahjYVI9G9kWY0vAw2 content esgSubNav
In This List

ReShape Lifesciences buys Apollo Endosurgery's gastric surgery products for $17M

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


ReShape Lifesciences buys Apollo Endosurgery's gastric surgery products for $17M

ReShape Lifesciences Inc. has purchased Apollo Endosurgery Inc.'s surgical product line, which includes an adjustable gastric band surgically installed around the stomach for weight loss, in a cash transaction of $17 million.

ReShape Lifesciences made an up-front payment of $10 million and also gave Apollo its intragastric balloon product line, which are inflatable medical devices placed into the stomach when diet and exercise have failed and surgery is not an option.

The remaining amount will be paid to Austin, Texas-based Apollo Endosurgery in yearly installments. Apollo Endosurgery will have the legal right to get back its surgical product line until San Clemente, Calif.-based ReShape Lifesciences either makes the full payment or raises $15 million through a qualified offering.

ReShape Lifesciences develops devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.

Cooley LLP was legal adviser to Apollo Endosurgery for the transaction, which closed Dec. 17.